EIM
IMGN

Essex Investment Management’s Immunogen Inc IMGN Stock Holding History

Essex Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,443
Closed -$118K – 384
2023
Q3 		$118K Buy
+7,443
New +$124K 0.02% 290
2018
Q4 		– Sell
-61,676
Closed -$584K – 543
2018
Q3 		$584K Buy
+61,676
New +$593K 0.07% 289

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Essex Investment Management's IMGN Position: Q4 2023 in Review

Essex Investment Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 7,443 shares — an estimated $118K sold.

Essex Investment Management first reported a position in IMGN in Q3 2018 and held it in 2 quarters. The position peaked at $584K in Q3 2018. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Essex Investment Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Essex Investment Management sold 7,443 Immunogen Inc shares in Q4 2023, an estimated $118K.
  • Essex Investment Management first reported a position in Immunogen Inc in Q3 2018 and held it in 2 quarters.
  • Essex Investment Management's Immunogen Inc position peaked at $584K in Q3 2018.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Essex Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.